Kidney Function Assessment in Cancer Patients
Author Information
Author(s): M.W. Lindegaard, N. Aass, E.S. Bue, L. Theodorsen, S.D. Fossa
Primary Institution: The Norwegian Radium Hospital
Hypothesis
The study aims to compare Hippuran clearance and creatinine clearance with GFR in cancer patients.
Conclusion
The study confirms that Hippuran clearance is a valid measure of renal function and highlights the importance of GFR assessment in cancer patients.
Supporting Evidence
- The correlation coefficient between Hippuran clearance and GFR was found to be 0.91.
- The mean difference between Hippuran clearance and GFR was 0.4 ml min-1.73 m2.
- Creatinine clearance estimations were influenced by muscle mass and physical activity.
Takeaway
Doctors checked how well different tests measure kidney function in cancer patients, finding that one test works really well.
Methodology
The study involved measuring GFR using iohexol fluorescence technique and comparing it with Hippuran and creatinine clearance in 34 cancer patients.
Potential Biases
Potential bias from contamination of blood samples and variations in patient conditions.
Limitations
The study may have variability due to biological differences and methodological errors.
Participant Demographics
34 cancer patients, primarily with urogenital cancer, aged 18 to 80.
Want to read the original?
Access the complete publication on the publisher's website